Takeda Pharmaceutical (TAK) EBITDA (2018 - 2026)
Takeda Pharmaceutical (TAK) posted EBITDA of $2.29 billion for the quarter ended Jun 30, 2026, down 9.7% from $2.53 billion a year earlier and down 9.1% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) EBITDA (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Takeda Pharmaceutical was $10.63 billion, down 19.7% year-over-year; for the year ended Mar 31, 2026, it was $4.83 billion, down 33.3% from the prior year.
- Annual EBITDA shows a five-year compound annual growth rate of -13.7% (years ended Mar 2021 to Mar 2026).
- In prior years, Takeda Pharmaceutical's EBITDA was $7.25 billion in the year ended Mar 31, 2025 (+10.9%), $6.53 billion in the year ended Mar 31, 2024 (-23.6%), $8.55 billion in the year ended Mar 31, 2023 (-8.1%) and $9.3 billion in the year ended Mar 31, 2022 (-7.8%).
- Quarterly EBITDA has run from a low of -$1.47 billion in the quarter ended Dec 31, 2025 to a high of $7.46 billion in the quarter ended Sep 30, 2023 over five years.
- On a year-over-year basis, EBITDA increased in two of the last seven quarters, with an average decline of 9.4%.
- The strongest year-over-year quarter for EBITDA in the past five years was the quarter ended Sep 30, 2023, with growth of 58.7%; the weakest was the quarter ended Dec 31, 2024, with a decline of 60.5%.
- According to Business Quant data, EBITDA for the three prior quarters was $2.51 billion (quarter ended Mar 31, 2026), -$1.47 billion (quarter ended Dec 31, 2025) and $7.29 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 2.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Bn |
| Mar 31, 2026 | 2.51 Bn |
| Dec 31, 2025 | -1.47 Bn |
| Sep 30, 2025 | 7.29 Bn |
| Jun 30, 2025 | 2.53 Bn |
| Mar 31, 2025 | 2.64 Bn |
| Dec 31, 2024 | 737.07 Mn |
| Sep 30, 2024 | 7.33 Bn |
| Jun 30, 2024 | 2.30 Bn |
| Mar 31, 2024 | 2.61 Bn |
| Dec 31, 2023 | 1.86 Bn |
| Sep 30, 2023 | 7.46 Bn |
| Jun 30, 2023 | 2.48 Bn |
| Mar 31, 2023 | 2.63 Bn |
| Dec 31, 2022 | 2.29 Bn |
| Sep 30, 2022 | 4.70 Bn |
| Jun 30, 2022 | 2.39 Bn |
| Jun 30, 2021 | 3.58 Bn |
| Mar 31, 2021 | 3.67 Bn |
| Jun 30, 2020 | 2.87 Bn |
API Access
Takeda Pharmaceutical EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();